|
1
|
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon.
|
Oncotarget
|
2012
|
1.55
|
|
2
|
Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells.
|
Biochim Biophys Acta
|
2003
|
1.16
|
|
3
|
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells.
|
Ann N Y Acad Sci
|
2004
|
1.09
|
|
4
|
Molecular mechanisms of sorafenib action in liver cancer cells.
|
Cell Cycle
|
2012
|
1.01
|
|
5
|
Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors.
|
Ann N Y Acad Sci
|
2004
|
0.99
|
|
6
|
Involvement of p38 and JNK MAPKs pathways in Substance P-induced production of TNF-alpha by peritoneal mast cells.
|
Cytokine
|
2002
|
0.93
|
|
7
|
Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
|
Cancer Biol Ther
|
2007
|
0.92
|
|
8
|
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth.
|
Ann N Y Acad Sci
|
2009
|
0.88
|
|
9
|
Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery.
|
J Drug Target
|
2007
|
0.83
|
|
10
|
COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.
|
OMICS
|
2011
|
0.82
|
|
11
|
Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.
|
PLoS One
|
2013
|
0.79
|